Targeted sensitization of tumor cells for radiation through monocarboxylate transporters 1 and 4 inhibition in vitro.
MCT inhibition
Monocarboxylate transporter
lactate
radiation resistance
radiation sensitization
tumor metabolism
Journal
Clinical oral investigations
ISSN: 1436-3771
Titre abrégé: Clin Oral Investig
Pays: Germany
ID NLM: 9707115
Informations de publication
Date de publication:
Jan 2021
Jan 2021
Historique:
received:
03
07
2019
accepted:
19
05
2020
pubmed:
5
6
2020
medline:
8
1
2021
entrez:
5
6
2020
Statut:
ppublish
Résumé
Monocarboxylate transporters (MCT) 1, 2 and 4 play an important role in tumor metabolism. The amount of lactate transported by MCT's highly correlates with overall survival. Furthermore, glycolysis and hypoxia are possible causes for radiation resistance. An oral squamous cell carcinoma cell line (CAL27, ATCC) was analyzed in an in vitro cell assay. After incubation with two different inhibitors for MCT1 (AR-C122982/SR-13800 and AR-C155858/SR-13801, Tocris) or for MCT4 (simvastatin, Sigma-Aldrich and 2-cyano-3-(4-hydroxyphenyl)-2-propenoic acid (CHC), Tocris), cells were irradiated with six gray with a Gammacell 2000 (Nuklear Data). For analysis, cell counting assay, wound healing assay, MTT assay and clonogenic assay were applied. Cell counting assay showed significant lower results for simvastatin, CHC and for the highest concentrations of AR-C122982 and AR-C155858 (p < 0.03). Additionally, cell counts decreased significantly with irradiation after 72 hours (p < 0.05) only for AR-C122982, CHC and simvastatin. The clonogenic assay confirmed these results with substantially reduced growth when incubated with CHC, simvastatin and AR-C155858 (p < 0.002). Furthermore, MCT1 and 4 inhibition led to highly reduced migration (p < 0.05). There again, comparing the wound healing assay of irradiated to non-irradiated tests showed contrary results (controls: p < 0.001; AR-C155858: p > 0.05; AR-C122982: p > 0.32; CHC: p > 0.1; simvastatin p > 0.1). The MTT assay presented significant effects with MCT1 and 4 inhibition (simvastatin/AR-C122982/CHC: p < 0.007). Irradiated cells showed significantly lower expression after only 48 h compared to non-irradiated cells (simvastatin/AR-C122982/CHC: p < 0.02). Inhibition of MCT, especially MCT4 may represent a possible tool to overcome radiation resistance in tumor cell lines. MCT Inhibitors may be used as a possible therapeutic approach to sensitize OSCC to radiation.
Identifiants
pubmed: 32495222
doi: 10.1007/s00784-020-03364-8
pii: 10.1007/s00784-020-03364-8
doi:
Substances chimiques
Monocarboxylic Acid Transporters
0
Symporters
0
Types de publication
Journal Article
Langues
eng
Pagination
295-310Références
Ferlay J, Shin HR, Bray F, Forman D, Mathers C, Parkin DM (2010) Estimates of worldwide burden of cancer in 2008: GLOBOCAN 2008. Int J Cancer 127(12):2893–2917
pubmed: 21351269
Taghavi N (2015) Prognostic factors of survival rate in oral squamous cell carcinoma: clinical, histologic, genetic and molecular concepts
Wolff KD, et al (2012) Diagnostik und Therapie des Mundhöhlenkarzinoms. AWMF Leitlinie (German treatment guidelines)
Lefebvre JL, Coche-Dequeant B, Buisset E, Mirabel X, Van JT, Prevost B (1994) Management of early oral cavity cancer. Experience of Centre Oscar Lambret. Eur J Cancer B Oral Oncol 30(3):216–220
Panje WR, Smith B, McCabe BF (1980) Epidermoid carcinoma of the floor of the mouth: surgical therapy vs combined therapy vs radiation therapy. Otolaryngol Head Neck Surg 88(6):714–720
pubmed: 7208038
Vikram B, Strong EW, Shah JP, Spiro R (1984) Failure in the neck following multimodality treatment for advanced head and neck cancer. Head Neck Surg 6(3):724–729
pubmed: 6693288
Bartelink H, Breur K, Hart G, Annyas B, van Slooten E, Snow G (1983) The value of postoperative radiotherapy as an adjuvant to radical neck dissection. Cancer 52(6):1008–1013
pubmed: 6883267
Teoule R (1987) Radiation-induced DNA damage and its repair. Int J Radiat Biol Related Stud Phys Chem Med 51(4):573–589
Brown JM (2000) Exploiting the hypoxic cancer cell: mechanisms and therapeutic strategies. Mol Med Today 6(4):157–162
pubmed: 10740254
Doherty JR, Yang C, Scott KE, Cameron MD, Fallahi M, Li W, Hall MA, Amelio AL, Mishra JK, Li F, Tortosa M (2014) Blocking lactate export by inhibiting the Myc target MCT1 disables glycolysis and glutathione synthesis. Cancer Res 74(3):908–920
pubmed: 24285728
Sattler UG, Meyer SS, Quennet V, Hoerner C, Knoerzer H, Fabian C, Mueller-Klieser W (2010) Glycolytic metabolism and tumour response to fractionated irradiation. Radiother Oncol 94(1):102–109
pubmed: 20036432
Sanli T et al (2010) Ionizing radiation activates AMP-activated kinase (AMPK): a target for radiosensitization of human cancer cells. Int J Radiat Oncol Biol Phys 78.1:221–229
Dancey JE (2006) Therapeutic targets: MTOR and related pathways. Cancer Biol Ther 5(9):1065–1073
pubmed: 16969122
Oka K, Nakano T, Hoshi T (1996) Analysis of response to radiation therapy of patients with cervical adenocarcinoma compared with squamous cell carcinoma: MIB-1 and PC10 labeling indices. Cancer 77(11):2280–2285
pubmed: 8635096
Kitaoka Y et al (2014) Effect of AMPK activation on monocarboxylate transporter (MCT) 1 and MCT4 in denervated muscle. J Physiol Sci 64(1):59–64
pubmed: 24081524
Chenal J, Pellerin L (2007) Noradrenaline enhances the expression of the neuronal monocarboxylate transporter MCT2 by translational activation via stimulation of PI3K/Akt and the mTOR/S6K pathway. J Neurochem 102(2):389–397
pubmed: 17394554
Warburg O, Wind F, Negelein E (1926) Ueber den stoffwechsel von tumoren im körper. Klin Wochenschr 5(19):829–832
Heiden V, Matthew G, Cantley LC, Thompson CB (2009) Understanding the Warburg effect: the metabolic requirements of cell proliferation. science 324.5930:1029–1033
Blatt S, Voelxen N, Sagheb K, Pabst AM, Walenta S, Schroeder T, Ziebart T (2016) Lactate as a predictive marker for tumor recurrence in patients with head and neck squamous cell carcinoma (HNSCC) post radiation: a prospective study over 15 years. Clin Oral Investig 20(8):2097–2104
pubmed: 26728026
Voelxen NF, Blatt S, Knopf P, Henkel M, Appelhans C, Righesso LA, Mueller-Klieser W (2018) Comparative metabolic analysis in head and neck cancer and the normal gingiva. Clin Oral Investig 22(2):1033–1043
pubmed: 28735466
Walenta S, Salameh A, Lyng H, Evensen JF, Mitze M, Rofstad EK, Mueller-Klieser W (1997) Correlation of high lactate levels in head and neck tumors with incidence of metastasis. Am J Pathol 150(2):409–415
pubmed: 9033256
pmcid: 1858285
Walenta S, Voelxen NF, Mueller-Klieser W (2016) Lactate—an integrative mirror of cancer metabolism. Metabolism in Cancer (pp. 23–37). Springer, Cham
Halestrap AP, Denton RM (1974) Specific inhibition of pyruvate transport in rat liver mitochondria and human erythrocytes by α-cyano-4-hydroxycinnamate. Biochem J 138(2):313–316
pubmed: 4822737
pmcid: 1166210
Halestrap AP (2012) The monocarboxylate transporter family—structure and functional characterization. IUBMB Life 64(1):1–9
pubmed: 22131303
Bonen A, Tonouchi M, Miskovic D, Heddle C, Heikkila JJ, Halestrap AP (2000) Isoform-specific regulation of the lactate transporters MCT1 and MCT4 by contractile activity. Am J Physiol-Endocrinol Metab 279(5):E1131–E1138
pubmed: 11052969
Pilegaard H, Domino K, Noland T, Juel C, Hellsten Y, Halestrap AP, Bangsbo J (1999) Effect of high-intensity exercise training on lactate/H+ transport capacity in human skeletal muscle. Am J Physiol-Endocrinol Metab 276(2):E255–E261
Sonveaux P, Végran F, Schroeder T, Wergin MC, Verrax J, Rabbani ZN, de Saedeleer CJ, Kennedy KM, Diepart C, Jordan BF, Kelley MJ, Gallez B, Wahl ML, Feron O, Dewhirst MW (2008) Targeting lactate-fueled respiration selectively kills hypoxic tumor cells in mice. J Clin Invest 118(12):3930–3942
pubmed: 19033663
pmcid: 2582933
Suzuki A, Stern SA, Bozdagi O, Huntley GW, Walker RH, Magistretti PJ, Alberini CM (2011) Astrocyte-neuron lactate transport is required for long-term memory formation. Cell. 144(5):810–823
pubmed: 21376239
pmcid: 3073831
Pellerin L, Halestrap AP, Pierre K (2005) Cellular and subcellular distribution of monocarboxylate transporters in cultured brain cells and in the adult brain. J Neurosci Res 79(1-2):55–64
pubmed: 15573400
Philp NJ, Yoon H, Grollman EF (1998) Monocarboxylate transporter MCT1 is located in the apical membrane and MCT3 in the basal membrane of rat RPE. Am J Phys Regul Integr Comp Phys 274(6):R1824–R1828
Dimmer KS, FRIEDRICH B, Florian LA, Deitmer JW, BRÖER S (2000) The low-affinity monocarboxylate transporter MCT4 is adapted to the export of lactate in highly glycolytic cells. Biochem J 350(1):219–227
pubmed: 10926847
pmcid: 1221245
Bonen A, Miskovic D, Tonouchi M, Lemieux K, Wilson MC, Marette A, Halestrap AP (2000) Abundance and subcellular distribution of MCT1 and MCT4 in heart and fast-twitch skeletal muscles. Am J Physiol-Endocrinol Metab 278(6):E1067–E1077
pubmed: 10827010
Zhu J, Wu YN, Zhang W, Zhang XM, Ding X, Li HQ, Geng M, Xie ZQ, Wu HM (2014) Monocarboxylate transporter 4 facilitates cell proliferation and migration and is associated with poor prognosis in oral squamous cell carcinoma patients. PLoS One 9(1):e87904
pubmed: 24498219
pmcid: 3907573
Ohno A, Yorita K, Haruyama Y, Kondo K, Kato A, Ohtomo T, Kawaguchi M, Marutuska K, Chijiiwa K, Kataoka H (2014) Aberrant expression of monocarboxylate transporter 4 in tumour cells predicts an unfavourable outcome in patients with hepatocellular carcinoma. Liver Int 34(6):942–952
pubmed: 24433439
Ullah MS, Davies AJ, Halestrap AP (2006) The plasma membrane lactate transporter MCT4, but not MCT1, is up-regulated by hypoxia through a HIF-1α-dependent mechanism. J Biol Chem 281(14):9030–9037
pubmed: 16452478
Eastman A (1995) Survival factors, intracellular signal transduction, and the activation of endonucleases in apoptosis. In: Seminars in cancer biology (Vol. 6, No. 1, pp. 45–52). Academic Press
Thews O, Gassner B, Kelleher DK, Schwerd G, Gekle M (2006) Impact of extracellular acidity on the activity of P-glycoprotein and the cytotoxicity of chemotherapeutic drugs. Neoplasia 8(2):143–152
pubmed: 16611407
pmcid: 1578510
Gioanni J, Fischel JL, Lambert JC, Demard F, Mazeau C, Zanghellini E, Ettore F, Formento P, Chauvel P, Lalanne CM, Courdi A (1988) Two new human tumor cell lines derived from squamous cell carcinomas of the tongue: establishment, characterization and response to cytotoxic treatment. Eur J Cancer Clin Oncol 24(9):1445–1455
pubmed: 3181269
Hanson DJ, Nakamura S, Amachi R, Hiasa M, Oda A, Tsuji D, Itoh K, Harada T, Horikawa K, Teramachi J, Miki H (2015) Effective impairment of myeloma cells and their progenitors by blockade of monocarboxylate transportation. Oncotarget. 6(32):33568–33586
pubmed: 26384349
pmcid: 4741786
Halestrap AP (1975) The mitochondrial pyruvate carrier. Kinetics and specificity for substrates and inhibitors. Biochem J 148(1):85–96
pubmed: 1156402
pmcid: 1165509
Kobayashi M, Otsuka Y, Itagaki S, Hirano T, Iseki K (2006) Inhibitory effects of statins on human monocarboxylate transporter 4. Int J Pharm 317(1):19–25
pubmed: 16621368
Mehibel M, Ortiz-Martinez F, Voelxen N, Boyers A, Chadwick A, Telfer BA, Stratford IJ (2018) Statin-induced metabolic reprogramming in head and neck cancer: a biomarker for targeting monocarboxylate transporters. Sci Rep 8(1):16804
pubmed: 30429503
pmcid: 6235971
Wu J, Hong Y, Wu T, Wang J, Chen X, Wang Z, Cheng B, Xia J (2018) Stromal-epithelial lactate shuttle induced by tumor-derived interleukin-1β promotes cell proliferation in oral squamous cell carcinoma. Int J Mol Med 41(2):687–696
pubmed: 29207019
Kikutani Y, Kobayashi M, Konishi T, Sasaki S, Narumi K, Furugen A, Takahashi N, Iseki K (2016) Involvement of monocarboxylate transporter 4 expression in statin-induced cytotoxicity. J Pharm Sci 105(4):1544–1549
pubmed: 26935883
Nielsen SF, Nordestgaard BG, Bojesen SE (2012) Statin use and reduced cancer-related mortality. N Engl J Med 367(19):1792–1802
pubmed: 23134381
Ovens MJ, Manoharan C, Wilson MC, Murray CM, Halestrap AP (2010) The inhibition of monocarboxylate transporter 2 (MCT2) by AR-C155858 is modulated by the associated ancillary protein. Biochem J 431(2):217–225
pubmed: 20695846
pmcid: 2947196
Polański R, Hodgkinson CL, Fusi A, Nonaka D, Priest L, Kelly P, Trapani F, Bishop PW, White A, Critchlow SE, Smith PD (2014) Activity of the monocarboxylate transporter 1 inhibitor AZD3965 in small cell lung cancer. Clin Cancer Res 20(4):926–937
pubmed: 24277449
Le Floch R, Chiche J, Marchiq I, Naiken T, Ilc K, Murray CM, Critchlow SE, Roux D, Simon MP, Pouysségur J (2011) CD147 subunit of lactate/H+ symporters MCT1 and hypoxia-inducible MCT4 is critical for energetics and growth of glycolytic tumors. Proc Natl Acad Sci 108(40):16663–16668
pubmed: 21930917
Nabeshima K, Iwasaki H, Koga K, Hojo H, Suzumiya J, Kikuchi M (2006) Emmprin (basigin/CD147): matrix metalloproteinase modulator and multifunctional cell recognition molecule that plays a critical role in cancer progression. Pathol Int 56(7):359–367
pubmed: 16792544
Whitaker-Menezes D, Martinez-Outschoorn UE, Lin Z, Ertel A, Flomenberg N, Witkiewicz AK, Birbe R, Howell A, Pavlides S, Gandara R, Pestell RG, Sotgia F, Philp NJ, Lisanti MP (2011) Evidence for a stromal-epithelial “lactate shuttle” in human tumors: MCT4 is a marker of oxidative stress in cancer-associated fibroblasts. Cell Cycle 10:1772–1783
pubmed: 21558814
pmcid: 3142461
Bola BM, Chadwick AL, Michopoulos F, Blount KG, Telfer BA, Williams KJ, Smith PD, Critchlow SE, Stratford IJ (2014) Inhibition of monocarboxylate transporter-1 (MCT1) by AZD3965 enhances radiosensitivity by reducing lactate transport. Mol Cancer Ther. molcanther-1091
Baumann F, Leukel P, Doerfelt A, Beier CP, Dettmer K, Oefner PJ, Bosserhoff AK (2009) Lactate promotes glioma migration by TGF-β2–dependent regulation of matrix metalloproteinase-2. Neuro-oncology 11(4):368–380
pubmed: 19033423
pmcid: 2743217
Wilson MC et al (2005) Basigin (CD147) is the target for organomercurial inhibition of monocarboxylate transporter isoforms 1 and 4: the ancillary protein for the insensitive MCT2 is EMBIGIN (gp70). J Biol Chem